REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Roche S.R.O. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing | Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Roche S.R.O. Profile Updated: March 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

ROCHE s.r.o. is a biotechnology company that focuses on research and development of new treatment options for oncological and autoimmune diseases, virology, and in vitro diagnostics. Their products are used for timely detection, prevention, diagnosis, and treatment of severe diseases, and are available in over 50 countries. ROCHE s.r.o. Diagnostics provides solutions for biomedical research, laboratory diagnosis, and health monitoring.

Headquarters
Sokolovska 685/136
Prague; The City of Prague; Postal Code: 18600

Contact Details: Purchase the Roche S.R.O. report to view the information.

Website: http://www.roche.cz

Basic Information
Total Employees:
Purchase the Roche S.R.O. report to view the information.
Registered Capital:
Purchase the Roche S.R.O. report to view the information.
Financial Auditors:
Purchase the Roche S.R.O. report to view the information.
Incorporation Date:
October 05, 1992
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Roche S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
7.74%▲
Total operating revenue
7.61%▲
Operating Profit/Loss (EBIT)
9.1%▲
EBITDA
15.38%▲
Net Profit/Loss for the Period
-16.44%▼
Total Assets
23.19%▲
Total Equity
-22.62%▼
Operating Profit Margin (ROS)
0.04%▲
Net Profit Margin
-0.6%▼
Return on Equity (ROE)
0.47%▲
Quick Ratio
-0.92%▼

Similar companies

Zentiva, K.S.
 
Novartis S.R.O.
Teva Czech Industries S.R.O.
 
Novavax Cz A.S.
Hartmann - Rico A.S.
 
Lohmann & Rauscher, S.R.O.
Molnlycke Health Care Procedurepak S.R.O.
 
Teva Pharmaceuticals Cr, S.R.O.
Pro.Med.Cs Praha A.S.
 
Janssen-Cilag S.R.O.
Bioveta, A.S.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo